METTL3 and colorectal cancer: They showed that METTL3‐mediated increase of m6A methylation and upregulation of the lncRNA NIFK‐AS1 resulted in lower OATP1B1 and OATP1B3 expression which led to reduced sorafenib uptake.[39] In colorectal cancer, increased YTHDF3 expression correlates with oxaliplatin resistance via enhanced expression of platinum drug transporters.